Science

Selective serotonin reuptake inhibitors (SSRIs) have long been the cornerstone of treatment for mood disorders, primarily anxiety and depression. With millions reliant on these medications, their efficacy has been widely discussed and scrutinized. Despite their popularity among healthcare providers and patients alike, serious questions remain about their long-term effectiveness, safety profiles, and the physiological underpinnings